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lower) [2] though the accurate causes for the association remain
unclear. In the study by Feld et al. [1], the body mass index
were not signiﬁcantly different amongst the groups, however,
the authors did not examine the effect of body mass index on
the high rates of sustained virologic response.
In addition, it is conﬁrmed that non-Hispanic whites are
more likely to have a sustained virologic response than black
persons regardless of the proportions of patients with genotype
1 infection [3]. However, the proportions of black persons were
overall low in the study by Feld et al. [1]. Are there any rela-
tions of the high rates of sustained virological response
24 weeks after the end of treatment to the low proportions
of black persons? In other words, could danoprevir/r, meric-
itabine plus PegIFNa-2a/ribavirin produce high rates of sus-
tained virological response 24 weeks after the end of
treatment in prior partial and null responders in black persons?
The above mentioned important issues should be assessed to
help further reﬁne treatment regimens in these partial and null
responders.
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To the Editor:
In the March issue of the Journal of Hepatology, Galbois and col-
leagues investigated the impact of skin mottling on outcome in
42 patients with cirrhosis admitted in intensive care unit (ICU)
for septic shock [1]. They reported that the large extent of skin
mottling as well its persistence were two strong predictors of
mortality. Indeed, in-ICU mortality reached 83% in cirrhosis
patients with septic shock having skin mottling at admission,
and none of the patients with persistent mottling for more than
six hours survived [1]. However, the study focused exclusively
on patients with septic shock, a subset of patients known to have
a particularly high mortality rate. As discussed by the authors,
this type of relationship between the occurrence of skin mottling
and the low survival rate cannot necessarily be extrapolated to
cirrhosis patients admitted in ICU for reasons other than septic
shock.
We recently reported the impact of skin mottling on outcome
in a non-selected population of patients admitted to ICU [2].
More precisely, we extracted data from our cohort in order to
assess the prognosis of all cirrhosis patients with skin mottling
whatever the reason for admission. Over a one-year period, 40
of the 791 patients included had cirrhosis (5.1%), which is in
keeping with the usual rates reported in general ICUs [3,4]. The
proportion of patients with skin mottling was signiﬁcantly higher
in patients with cirrhosis than in patients without cirrhosis: 45%
(18 of 40 patients) vs. 28% (212 of 751 patients) (p = 0.03), which
is slightly lower than the 57% rate reported by Galbois and col-
leagues [1]. However, the mortality rate of cirrhosis patients with
mottling in our cohort was only 22%, a rate markedly lower than
that reported in their study. Even though this was probably due
to the small sample of patients studied, we did not ﬁnd
signiﬁcant difference in mortality rate between cirrhosis patients
with skin mottling and those without skin mottling (Table 1).
Even in patients with persistent skin mottling for more than six
hours, in-ICU mortality was only 29% (4 of 14 patients), which
is not commensurate with the 100% mortality rate reported by
the present study in cirrhosis patients with septic shock [1].
The strikingly low mortality rate in our cohort is probably
explained by lower severity. Indeed, the simpliﬁed acute physiol-
ogy score (SAPS) II and the sequential organ failure assessment
(SOFA) score were only 41 [31–58] and 6.5 [3.3–11.8] in our
study versus 69 [52–86] and 14.0 [12.0–18.0] in the study by
Galbois and colleagues. It has been shown that the SAPS II score
was a strong predictor of mortality, even in septic patients with
cirrhosis [3]. The SOFA score, which assesses the number of organ
dysfunctions induced during septic shock [5], is also a relevant
predictor of mortality in cirrhosis patients [6]. Despite a trend
over recent years favouring better outcome, admission to ICU
for septic shock remains associated with high mortality,
especially in cirrhosis patients who are at high risk for multiple
organ failure [3]. Although skin mottling could indicate suboptimal
hemodynamic resuscitation, the extremely high mortality rate
reported by Galbois and colleagues may be due to the speciﬁc
population of patients studied, i.e. the patients with cirrhosis
admitted to ICU for septic shock and multiple organ dysfunctions.
It has been found that skin mottling was a risk factor of mortality
not only in patients with septic shock [7] but also in non-selected
patients admitted in ICU for another reason [2]. From our770 Journal of Hepatology 2015 vol. 63 j 763–773
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Table 1. Baseline characteristics of the 40 cirrhosis patients admitted to our ICU over a one-year period.
Skin mottling
(n = 18)
No skin mottling
(n = 22)
p value
Age, years, median (interquartile) 59 (57-63) 59 (49-68) 0.99
Sex, male, n (%) 11 (61) 18 (82) 0.17
Child-Pugh class C, n (%) 5 (28) 2 (9.1) 0.21
Child-Pugh score, median (interquartile) 7 (5-12) 7 (6-9) 0.92
Diagnosis at admission 0.11
Cardiac arrest, n (%) 3 (17) 1 (4.5)
Shock, n (%) 7 (39) 4 (18)
Acute respiratory failure, n (%) 1 (5.6) 7 (32)
Coma, n (%) 4 (22) 8 (36)
Others, n (%) 3 (17) 2 (9.1)
At intensive care unit admission
Simplified acute physiology score II, median (interquartile) 46 (35-62) 38 (26-45) 0.08
Sequential organ failure assessment score, median (interquartile) 8.5 (5.0-12.5) 5.5 (2.0-10.3) 0.06
During intensive care unit stay
Mechanical ventilation, n (%) 13 (72) 8 (36) 0.03
Vasopressor use, n (%) 9 (50) 5 (23) 0.10
Renal replacement therapy, n (%) 5 (28) 1 (4.5) 0.07
Outcomes
Length of intensive care unit stay, days, median (interquartile) 10 (6-13) 4 (3-6) 0.01
In-intensive care unit mortality, n (%) 4 (22) 2 (9.1) 0.38
Data are expressed in median (interquartile) according to their distribution using the Kolmogorov–Smirnov test. Continuous variables are compared using the
Mann–Whitney test, and categorical variables using the Fisher exact test.
JOURNAL OF HEPATOLOGYobservations, the impact of skin mottling on outcome of cirrhotic
patients nonetheless seems to be markedly lower when they are
admitted to ICU for a reason other than septic shock.
Therefore, skin mottling could be an early severity sign
associated with worse outcomes. This easy-to-assess clinical sign
could help to promptly discriminate high-risk patients requiring
ICU admission or treatment intensiﬁcation to relieve this sign of
poor peripheral perfusion.
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